Prostate Cancer Marker May Be Masked By Anti-Inflammatory Drugs
Chronic inflammation has been linked to a host of health issues including prostate cancer. New research suggests a significant correlation between use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen and reduced serum levels of the prostate biomarker, PSA (prostate specific antigen), making early detection of prostate cancer somewhat more risky.
